Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

Some patients with psoriasis may have a super response to guselkumab, but questions remain regarding the generalizability of treatment strategies.

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

Positive results were reported for Johnson & Johnson's psoriasis drug during.a late-breaking research session today at the ...

Growing awareness of psoriasis as a significant health issue has driven research and development efforts, leading to new treatment alternatives. Biologic drugs, focusing on specific elements of ...

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...

BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd ... Ustekinumab in the treatment of moderate to severe chronic plaque psoriasis and by extension ...

(MENAFN- GlobeNewsWire - Nasdaq) Advancements in biologics, personalized medicine, and rising global prevalence drive the psoriasis treatment market's exponential growth. Pune, March 12 ...